Literature DB >> 19601887

MicroRNA regulatory network in human colorectal cancer.

Jie-Ting Tang1, Jing-Yuan Fang.   

Abstract

Epigenetic modifications include DNA methylation, histone modifications, and noncoding RNAs containing microRNAs (miRNA). miRNAs are small noncoding RNAs that are 21 to 25 nt in length; they downregulate gene expression during cell development, cell proliferation, cell differentiation, and apoptosis. They play a critical role in human carcinogenesis. Presently, evidences show that miRNAs participate as oncogenic miRNAs or tumor suppressors in the developmental and physiological processes of human colorectal cancer (CRC). Disturbed miRNA expression may be attributable to a mechanism involving multiple factors. In this review, we focus on the colorectal miRNA expression profile and further discuss the miRNA regulatory network involved in the tumorigenesis of human CRC. We, thus, hope to open up new avenues for anticancer therapy based on the epigenetic regulation of miRNA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19601887     DOI: 10.2174/138955709788681672

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  12 in total

1.  Integrative analysis of microRNA and mRNA expression profiles in non-small-cell lung cancer.

Authors:  C Yang; C Sun; X Liang; S Xie; J Huang; D Li
Journal:  Cancer Gene Ther       Date:  2016-03-11       Impact factor: 5.987

2.  Plasma and saliva miR-21 expression in colorectal cancer patients.

Authors:  A A Sazanov; E V Kiselyova; A A Zakharenko; M N Romanov; M I Zaraysky
Journal:  J Appl Genet       Date:  2016-12-02       Impact factor: 3.240

Review 3.  MicroRNAs in cancer diagnosis and therapy: from bench to bedside.

Authors:  Isamu Hoshino; Hisahiro Matsubara
Journal:  Surg Today       Date:  2012-11-06       Impact factor: 2.549

4.  MiRNA-15a inhibits proliferation, migration and invasion by targeting TNFAIP1 in human osteosarcoma cells.

Authors:  Xu Tian; Jian Zhang; Liang Yan; Jing-Ming Dong; Qiang Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 5.  MicroRNA-21 as a potential colon and rectal cancer biomarker.

Authors:  Tao Li; Mei Ha Leong; Bruce Harms; Gregory Kennedy; Lin Chen
Journal:  World J Gastroenterol       Date:  2013-09-14       Impact factor: 5.742

6.  Association between microRNA genetic variants and susceptibility to colorectal cancer in Chinese population.

Authors:  Xuejiao Hu; Lixin Li; Mengqiao Shang; Juan Zhou; Xingbo Song; Xiaojun Lu; Jun Wang; Binwu Ying; Lanlan Wang
Journal:  Tumour Biol       Date:  2013-10-18

7.  Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer.

Authors:  Kristina Schee; Susanne Lorenz; Merete Molton Worren; Clara-Cecilie Günther; Marit Holden; Eivind Hovig; Oystein Fodstad; Leonardo A Meza-Zepeda; Kjersti Flatmark
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

8.  MicroRNA-424 is down-regulated in hepatocellular carcinoma and suppresses cell migration and invasion through c-Myb.

Authors:  Lei Yu; Guo-feng Ding; Changzhi He; Lei Sun; YanFang Jiang; Liying Zhu
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.752

9.  MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma.

Authors:  Lei Shen; Peng Wang; Jili Yang; Xiaotao Li
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

10.  MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.

Authors:  Bo-Chuan Lin; Dong Huang; Chao-Qun Yu; Yong Mou; Yuan-Hang Liu; Da-Wei Zhang; Feng-Jun Shi
Journal:  Med Sci Monit       Date:  2016-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.